Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Articles published by Cardio Diagnostics Holdings, Inc.
Cardio Diagnostics Announces Publication of Study Showing That its PrecisionCHD™ Test Could Save Health Insurers Over $113 Million Annually
April 29, 2024
From
Cardio Diagnostics Holdings, Inc.
Via
Business Wire
Tickers
CDIO
Exponential Health Partners with Cardio Diagnostics to Elevate Cardiovascular Disease Prevention in Michigan
April 09, 2024
From
Cardio Diagnostics Holdings, Inc.
Via
Business Wire
Tickers
CDIO
Cardio Diagnostics Holdings, Inc. Enters Into a Nationwide Telehealth Agreement with Navierre
April 04, 2024
From
Cardio Diagnostics Holdings, Inc.
Via
Business Wire
Tickers
CDIO
Cardio Diagnostics Holdings, Inc. to Showcase HeartRisk and Actionable Clinical Intelligence Version 3 at the American College of Cardiology’s 73rd Annual Scientific Session
March 14, 2024
From
Cardio Diagnostics Holdings, Inc.
Via
Business Wire
Tickers
CDIO
Cardio Diagnostics Holdings, Inc. Announces Issuance of Second U.S. Patent for Compositions and Methods for Detecting Predisposition to Cardiovascular Disease
March 05, 2024
From
Cardio Diagnostics Holdings, Inc.
Via
Business Wire
Tickers
CDIO
Cardio Diagnostics Holdings, Inc. Expands HeartRisk™ Platform Offering to Diverse Markets in Conjunction with Nationwide Rollout
February 15, 2024
From
Cardio Diagnostics Holdings, Inc.
Via
Business Wire
Tickers
CDIO
Cardio Diagnostics Holdings, Inc. Expands Partnership with Family Medicine Specialists to Bring Its Specialty Cardiology Tests to Select Walmart Supercenters
February 07, 2024
From
Cardio Diagnostics Holdings, Inc.
Via
Business Wire
Tickers
CDIO
Houston-Based resTOR Longevity Clinic to Offer Cardio Diagnostics' AI-Driven Epigenetic-Genetic Heart Disease Tests
February 05, 2024
From
Cardio Diagnostics Holdings, Inc.
Via
Business Wire
Tickers
CDIO
Cardio Diagnostics Holdings, Inc. Accelerates Cardiac Care Innovation with Appointment of Dr. Vimal Ramjee as Strategic Advisor
January 24, 2024
From
Cardio Diagnostics Holdings, Inc.
Via
Business Wire
Tickers
CDIO
Cardio Diagnostics Holdings, Inc. Announces the Grant of a Patent in India
January 08, 2024
From
Cardio Diagnostics Holdings, Inc.
Via
Business Wire
Tickers
CDIO
CORRECTING and REPLACING Cardio Diagnostics Holdings, Inc. Unveils Groundbreaking Employer Cardiovascular Disease Risk Intelligence Platform, HeartRisk™
January 04, 2024
From
Cardio Diagnostics Holdings, Inc.
Via
Business Wire
Tickers
CDIO
American Medical Association (AMA) Grants Cardio Diagnostics a Dedicated CPT PLA Reimbursement Code for Epi+Gen CHD, an AI-powered Test for Assessing the Probability of a Heart Attack or Coronary Heart Disease Event
January 03, 2024
From
Cardio Diagnostics Holdings, Inc.
Via
Business Wire
Tickers
CDIO
American Medical Association (AMA) Grants Cardio Diagnostics Holdings, Inc.’s AI-Powered Coronary Heart Disease Detection Test, PrecisionCHD, a Dedicated CPT PLA Reimbursement Code
January 02, 2024
From
Cardio Diagnostics Holdings, Inc.
Via
Business Wire
Tickers
CDIO
Cardio Diagnostics Holdings, Inc. Appoints Biotechnology Investor, Executive & Serial Entrepreneur Paul Burton to its Board of Directors
December 21, 2023
From
Cardio Diagnostics Holdings, Inc.
Via
Business Wire
Tickers
CDIO
Cardio Diagnostics Holdings, Inc. Regains Nasdaq Minimum Bid Price Requirement
December 06, 2023
From
Cardio Diagnostics Holdings, Inc.
Via
Business Wire
Tickers
CDIO
CORRECTING and REPLACING Cardio Diagnostics Holdings, Inc. Convenes Cardiovascular Care & Risk Roundtable at the 42nd Annual J.P. Morgan Healthcare Conference
December 04, 2023
From
Cardio Diagnostics Holdings, Inc.
Via
Business Wire
Tickers
CDIO
Cardio Diagnostics Holdings, Inc. Announces Breakthrough in Coronary Heart Disease Detection with PrecisionCHD Test, Published in the Journal of the American Heart Association
November 20, 2023
From
Cardio Diagnostics Holdings, Inc.
Via
Business Wire
Tickers
CDIO
Family Medicine Specialists Selects Cardio Diagnostics’ Epigenetic-Genetic Tests for Assessing Heart Attack Risk for its BlueCross BlueShield Patients
November 07, 2023
From
Cardio Diagnostics Holdings, Inc.
Via
Business Wire
Tickers
CDIO
Cardio Diagnostics Holdings, Inc. to List on Nasdaq Following Successful Business Combination with Mana Capital Acquisition Corp.
October 26, 2022
From
Cardio Diagnostics Holdings, Inc.
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.